Hawaii · 2025 Regular Session · Concurrent Resolution

SCR 8: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION.

Passed one chamber Last action April 14, 2025: Reported from HLT (Stand. Com. Rep. No. 2071), recommending referral to FIN.

Plain-language summary

SCR 8 is a concurrent resolution introduced in the Hawaii Senate on January 30, 2025. According to its official title, it concerns: REQUESTING THE AUDITOR TO ASSESS BOTH THE SOCIAL AND FINANCIAL EFFECTS OF PROPOSED MANDATED HEALTH INSURANCE COVERAGE FOR A PERCENTAGE OF THE COSTS OF INTRAVENOUS KETAMINE THERAPY TO TREAT DEPRESSION. Primary sponsor: Kurt Fevella (Republican). Most recent recorded action (April 14, 2025): Reported from HLT (Stand. Com. Rep. No. 2071), recommending referral to FIN.

Sponsors

Primary sponsor: Kurt Fevella (Republican).